Skip to content

Skin Reactions to Cancer Immunotherapy

Search Clinical Trials

Trial Objectives

A new cancer treatment, called immunotherapy, enhances the body’s immune response to attack and kill cancers. However, by changing the body’s immune response, unwanted side effects can occur. This study focuses on side effects caused by immunotherapy, specifically skin reactions. The purpose of this study is to understand what changes in the immune system, and how these changes lead to skin reactions as a side effect. By understanding these changes, our goal is to define the best treatment for the skin reactions, or possibly prevent the reactions.

Who Can Participate

Adults who have been diagnosed with a solid tumor who are starting or already receiving immunotherapy for cancer treatment.

Age: 18+ Gender: Any

Estimated Time Commitment

Up to 2 visits over 3 months, with possible phone follow-up after 12 months depending on cancer treatment response

Payment & Reimbursement

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Daniell Plomondon

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Principal Investigators

  • Jeffrey Kern

    Jeffrey Kern, MD

  • Donald Y M Leung

    Donald Y M Leung, PhD, MD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required